1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with emedastine in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (emedastine) | Trials (emedastine) | Recent Studies (post-2010) (emedastine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 79 | 23 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parnell, DW; Spellman, JM; Stephens, DJ; Yanni, JM | 1 |
| el-Shazly, AE; Eura, M; Ishikawa, T; Masuyama, K; Samejima, Y | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and emedastine
| Article | Year |
|---|---|
Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.
Topics: Administration, Topical; Anaphylaxis; Animals; Benzimidazoles; Capillary Permeability; Conjunctiva; Conjunctivitis, Allergic; Drug Evaluation, Preclinical; Guinea Pigs; Histamine; Histamine H1 Antagonists; Male; Ophthalmic Solutions; Ovalbumin; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Serotonin | 1994 |
Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
Topics: Anti-Allergic Agents; Benzimidazoles; Cells, Cultured; Chemotaxis, Leukocyte; Eosinophils; Histamine H1 Antagonists; Humans; Neutrophils; Platelet Activating Factor | 1996 |